Correlates of myocardial fibrosis in hypertrophic cardiomyopathy

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy

Bibliographic Details
Main Authors:	Kramer, CM, Appelbaum, E, Desai, MY, Desvigne-Nickens, P, DiMarco, JP, Dolman, S, Friedrich, MF, Geller, N, Ho, CY, Jerosch-Herold, M, Kim, D-Y, Kolm, P, Kwong, RY, Maron, MS, Schulz-Menger, J, Piechnik, S, Watkins, H, Weintraub, WS, Neubauer, S
Format:	Conference item
Language:	English
Published:	American Heart Association 2018

Similar Items

Predictors of clinically significant atrial fibrillation in the NHLBI hypertrophic cardiomyopathy registry (HCMR)
by: Kramer, C, et al.
Published: (2020)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
by: Neubauer, S, et al.
Published: (2019)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
by: Neubauer, S, et al.
Published: (2019)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric MRI
by: Petersen, S, et al.
Published: (2007)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
by: Raman, B, et al.
Published: (2017)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
by: Karamitsos, T, et al.
Published: (2013)

Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy
by: Zhang, Q, et al.
Published: (2021)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
by: Petersen, SE, et al.
Published: (2007)

Myocardial T1 mapping and extracellular volume quantification: an overview of technical and biological confounders
by: Piechnik, S, et al.
Published: (2017)

Left and right ventricular tissue velocities are reduced in hypertrophic cardiomyopathy but not in athlete's heart
by: Petersen, SE, et al.
Published: (2008)

Reduced hyperemic myocardial blood flow in hypertrophic cardionnyopathy: New insights from multi-parametric magnetic resonance imaging
by: Petersen, SE, et al.
Published: (2006)

Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
by: Aung, N, et al.
Published: (2023)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2018)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
by: Ariga, R, et al.
Published: (2019)

2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
by: Manning Warren J, et al.
Published: (2008-10-01)

Fibrotic content of LV myocardium quantified by CMR characterizes left atrial sizes and total left atrial emptying function incremental to LV functional parameters and LV myocardial mass index in patients with hypertrophic cardiomyopathy
by: Chen Yucheng, et al.
Published: (2012-02-01)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
by: Manning Warren J, et al.
Published: (2008-10-01)

In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.
by: Dass, S, et al.
Published: (2011)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
by: Petersen, SE, et al.
Published: (2009)

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
by: Dong T, et al.
Published: (2023-04-01)

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
by: Gibson C Michael, et al.
Published: (2008-10-01)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
by: Maron Martin S
Published: (2012-02-01)

Quality control-driven deep ensemble for accountable automated segmentation of cardiac magnetic resonance LGE and VNE images
by: Gonzales, RA, et al.
Published: (2023)

Quality control-driven framework for reliable automated segmentation of cardiac magnetic resonance LGE and VNE images
by: Gonzales, RA, et al.
Published: (2023)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
by: Jiri Bonaventura, et al.
Published: (2023-06-01)

Is the 12-lead electrocardiogram of value in the prognostic assessment of patients with hypertrophic cardiomyopathy?
by: Udelson James E, et al.
Published: (2010-01-01)

Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
by: Dass, S, et al.
Published: (2013)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
by: N. T. Vatutin, et al.
Published: (2014-05-01)

Myocardial dysfunction in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2001)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
by: Rowin Ethan, et al.
Published: (2013-01-01)

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices
by: Ewen E, et al.
Published: (2012-10-01)

233 Evidence that post-contrast delayed enhancement identified by cardiovascular magnetic resonance is an arrhythmogenic substrate in hypertrophic cardiomyopathy
by: Udelson James E, et al.
Published: (2008-10-01)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
by: Ashrafian, H, et al.
Published: (2005)

Discrepancy between pathological progression and clinical stability in a young patient with hypertrophic cardiomyopathy
by: Raman, B, et al.
Published: (2018)

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
by: Waring, A, et al.
Published: (2020)